A Daver

2.1k total citations
48 papers, 1.1k citations indexed

About

A Daver is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, A Daver has authored 48 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 14 papers in Cancer Research and 13 papers in Pathology and Forensic Medicine. Recurrent topics in A Daver's work include Genetic factors in colorectal cancer (12 papers), Colorectal Cancer Treatments and Studies (7 papers) and Breast Cancer Treatment Studies (6 papers). A Daver is often cited by papers focused on Genetic factors in colorectal cancer (12 papers), Colorectal Cancer Treatments and Studies (7 papers) and Breast Cancer Treatment Studies (6 papers). A Daver collaborates with scholars based in France and United States. A Daver's co-authors include J.-P. Daurès, Jean-Louis Pujol, F Larra, H Pujol, F.B. Michel, Jean‐Christophe Grenier, Jean-Pierre Muratet, Jean‐Michel Bidart, Jacqueline Chalas and Nelly Jacob and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and International Journal of Cancer.

In The Last Decade

A Daver

46 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Daver France 15 361 354 270 242 193 48 1.1k
G.J. Fleuren Netherlands 21 284 0.8× 321 0.9× 122 0.5× 337 1.4× 137 0.7× 37 1.6k
Atsushi Hongo Japan 26 482 1.3× 829 2.3× 184 0.7× 246 1.0× 404 2.1× 58 2.0k
Jacob R. Izbicki Germany 18 576 1.6× 284 0.8× 357 1.3× 394 1.6× 56 0.3× 47 1.3k
Kurt T. Patton United States 16 276 0.8× 308 0.9× 335 1.2× 297 1.2× 62 0.3× 22 1.6k
H Sawada Japan 15 503 1.4× 669 1.9× 404 1.5× 239 1.0× 51 0.3× 39 1.3k
José María Sayagués Spain 23 292 0.8× 367 1.0× 131 0.5× 202 0.8× 77 0.4× 66 1.3k
M Droese Germany 16 386 1.1× 261 0.7× 146 0.5× 432 1.8× 100 0.5× 82 968
Włodzimierz Olszewski Poland 19 476 1.3× 289 0.8× 492 1.8× 120 0.5× 71 0.4× 51 1.1k
Tony Elliott United Kingdom 22 503 1.4× 326 0.9× 736 2.7× 535 2.2× 94 0.5× 58 1.6k
Derek Atkins Germany 20 544 1.5× 568 1.6× 299 1.1× 184 0.8× 27 0.1× 27 1.5k

Countries citing papers authored by A Daver

Since Specialization
Citations

This map shows the geographic impact of A Daver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Daver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Daver more than expected).

Fields of papers citing papers by A Daver

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Daver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Daver. The network helps show where A Daver may publish in the future.

Co-authorship network of co-authors of A Daver

This figure shows the co-authorship network connecting the top 25 collaborators of A Daver. A scholar is included among the top collaborators of A Daver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Daver. A Daver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tuech, Jean‐Jacques, Patrick Pessaux, Nicolas Régenet, et al.. (2004). Detection of occult liver metastases in colorectal cancer by measurement of biliary carcinoembryonic antigen concentration: A prospective study. Journal of Surgical Oncology. 88(1). 27–31. 5 indexed citations
2.
Chautard, Denis, et al.. (2004). Prognostic value of uPA, PAI-1, and dna content in adult renal cell carcinoma. Urology. 63(6). 1055–1060. 14 indexed citations
3.
Basuyau, J P, M P Blanc-Vincent, Jean‐Michel Bidart, et al.. (2003). Summary report of the Standards, Options and Recommendations for the use of serum tumour markers in breast cancer: 2000. British Journal of Cancer. 89(S1). S32–S34. 9 indexed citations
4.
Eche, N., M. Pichon, Véronique Quillien, et al.. (2001). [Standards, options and recommendations for tumor markers in colorectal cancer].. PubMed. 88(12). 1177–206. 14 indexed citations
5.
Broët, Philippe, S Romain, A Daver, et al.. (2001). Thymidine Kinase as a Proliferative Marker: Clinical Relevance in 1,692 Primary Breast Cancer Patients. Journal of Clinical Oncology. 19(11). 2778–2787. 77 indexed citations
6.
Basuyau, J P, M P Blanc-Vincent, Jean‐Michel Bidart, et al.. (2000). [Standards, Options and Recommendations (SOR) for tumor markers in breast cancer. SOR Working Group].. PubMed. 87(10). 723–37. 16 indexed citations
7.
Uhrhammer, Nancy, J.-O. Bay, Fabrice Kwiatkowski, et al.. (2000). Allelic imbalance at NBS1 is frequent in both proximal and distal colorectal carcinoma.. Oncology Reports. 7(2). 427–31. 9 indexed citations
8.
Sauvaigo, Sylvie, A Daver, Martin Pagé, et al.. (2000). Specific H-Ras minisatellite alleles in breast cancer susceptibility.. PubMed. 19(6B). 5191–6. 9 indexed citations
9.
Chautard, Denis, et al.. (2000). Comparison of the Bard Trak™ Test with Voided Urine Cytology in the Diagnosis and Follow–Up of Bladder Tumors. European Urology. 38(6). 686–690. 11 indexed citations
10.
Chautard, Denis, et al.. (1999). Values for the Free to Total Prostate-Specific Antigen Ratio as a Function of Age: Necessity of Reference Range Validation. European Urology. 36(3). 181–186. 12 indexed citations
11.
Sabatier, Robert, A Daver, M. Assicot, et al.. (1999). A new approach for clinical biological assay comparison and standardization: application of principal component analysis to a multicenter study of twenty-one carcinoembryonic antigen immunoassay kits.. PubMed. 45(6 Pt 1). 869–81. 14 indexed citations
12.
Koscielny, Serge, P. Terrier, A Daver, et al.. (1998). Quantitative determination of c-erbB-2 in human breast tumours: potential prognostic significance of low values. European Journal of Cancer. 34(4). 476–481. 22 indexed citations
13.
Muratet, Jean-Pierre, et al.. (1997). Predicting the efficacy of first iodine-131 treatment in differentiated thyroid carcinoma.. PubMed. 38(9). 1362–8. 47 indexed citations
14.
Gamelin, Érick, A Cailleux, Anne Le Bouil, et al.. (1997). Plasma sialic acid as a marker of the effect of the treatment on metastatic colorectal cancer. European Journal of Cancer. 33(13). 2216–2220. 18 indexed citations
15.
Pujol, Jean-Louis, Jean‐Christophe Grenier, J.-P. Daurès, et al.. (1993). Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer. Lung Cancer. 10(3-4). 274–274. 266 indexed citations
16.
Rousseau, Raphaël F., et al.. (1991). Méthodologie de la régression et de la prédiction fondée sur la classification automatique. French digital mathematics library (Numdam). 16(4). 479–488. 2 indexed citations
17.
Daver, A, Michael R. Page, A Chassevent, et al.. (1989). Flow cytometric analysis of DNA abnormalities in colorectal carcinomas.. PubMed. 76(3). 291–300. 4 indexed citations
18.
Page, Melissa M., et al.. (1987). Immunostaining of colorectal cancer with monoclonal anti-CEA antibodies compared to serum and tumor CEA content.. PubMed. 6(5). 893–6. 16 indexed citations
19.
Page, Michael J., et al.. (1985). Monoclonal anticarcinoembryonic antigen in immunohistochemical studies of colorectal cancer a comparison with tumor and serum carcinoembryonic antigen content. Anticancer Research. 5(6). 601. 1 indexed citations
20.
Chassevent, A, A Daver, G. Bertrand, F Larra, & Peter George. (1984). [Analysis of DNA by flow cytometry in breast cancer].. PubMed. 71(5). 494–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026